Bassel F. El‐Rayes
0000-0002-2661-5746
Publication & Citation Trends
Most Cited Works
Publications
698 total
Abstract 4579: Preclinical evaluation of a novel hyperbolic NAMPT inhibitor in combination with pan-RAS targeted therapies in pancreatic ductal adenocarcinoma
Cited by 0
Semantic Scholar
Abstract 413: ADT-007: A mechanistically distinct Pan-RAS inhibitor with capacity to escape acquired resistance common to other RAS inhibitors.
Cited by 0
Semantic Scholar
Abstract 7088: NAD(P)H: Quinone oxidoreductase 1 (NQO1): Is it a potential molecular target in colorectal cancer
Cited by 0
Semantic Scholar
A Phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling.
Cited by 1
Semantic Scholar
127 (PB115): Survival benefit and tumor regression with a dual RAS/β-catenin inhibitor, ADT-030, in murine models of pancreatic and lung cancer
Cited by 0
Semantic Scholar
133 (PB121): A novel pan-RAS inhibitor (ADT-1004) with superior efficacy over mutation-specific KRAS inhibitors in mouse models of pancreatic cancer
Cited by 0
Semantic Scholar
Refining colorectal cancer classification and clinical stratification through a single-cell atlas PDF
Cited by 195
OpenAlex
Research Topics
Pancreatic and Hepatic Oncology Research
(201)
Colorectal Cancer Treatments and Studies
(119)
Cancer Immunotherapy and Biomarkers
(73)
Cholangiocarcinoma and Gallbladder Cancer Studies
(68)
Hepatocellular Carcinoma Treatment and Prognosis
(66)
Frequent Co-Authors
Affiliations
American College of Radiology
Novartis (Switzerland)
Emory Healthcare
Hudson Institute
Mayo Clinic